Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • iGluR
    (6)
  • PKC
    (3)
  • GluR
    (2)
  • Others
    (3)
Filter
Search Result
Results for "

glua2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    11
    TargetMol | All_Pathways
  • Peptide Products
    8
    TargetMol | Peptide_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Antibody Products
    4
    TargetMol | Antibody_Products
TAT-GluA2 3Y acetate(1404188-93-7 free base)
TP2111L
TAT-GluA2 3Y acetate is an inhibitor of AMPA receptor endocytosis.Systemic administration of Tat-GluA2(3Y) during the induction phase of d-amphetamine blocked maintenance of behavioural sensitization and attenuated the maintenance of neurochemical sensitization of rat.
  • $86
In Stock
Size
QTY
TargetMol | Inhibitor Sale
p3Ysh-3
T76229
p3Ysh-3, a peptide inhibitor targeting the STEP Phosphatase-GluA2 AMPA receptor interaction, exhibits a Ki of 1.09 μM. It effectively reverses memory deficits and demonstrates anxiolytic and antidepressant effects in scopolamine-treated rat models, positioning itself as a promising lead compound for the development of novel cognitive enhancers and behavioral modulators [1].
  • Inquiry Price
Inquiry
Size
QTY
pep2-AVKI
TP19421315378-69-8
pep2-AVKI is an inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).
  • $277
Inquiry
Size
QTY
pep2-AVKI acetate(1315378-69-8 free base)
TP1942L1
pep2-AVKI acetate(1315378-69-8 free base) An inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to proteins that interact with C-kinase (PICK1). Does not affect GluA2 binding to GRIP or ABP, nor does it increase AMPA current amplitude or affect long-term depression (LTD).
  • $116
In Stock
Size
QTY
pep2-EVKI
TP19431315378-67-6
pep2-EVKI is an inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).
  • $239
Inquiry
Size
QTY
pep2-SVKI
TP1944328944-75-8
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and
  • $166
Inquiry
Size
QTY
Pep2m, myristoylated
TP19451423381-07-0
Cell-permeable, myristoylated form of pep2m. Peptide inhibitor of the interaction between the C-terminus of the GluA2 (AMPA receptor) subunit and N-ethylmaleimide-sensitive fusion protein (NSF), a protein that regulates AMPA receptor function. Reduces pos
  • $219
Inquiry
Size
QTY
Pep2m, myristoylated acetate
Pep2m, myristoylated acetate(1423381-07-0 free base)
TP1945L1
Pep2m, myristoylated acetate is a Cell-permeable, myristoylated form of pep2m. Peptide inhibitor of the interaction between the C-terminus of the GluA2 (AMPA receptor) subunit and N-ethylmaleimide-sensitive fusion protein (NSF), a protein that regulates A
  • $95
In Stock
Size
QTY